Physician profile
Jennifer Dyott
NPI 1508294745
$647.79
in general payments reported to CMS, 2019-2025
14 companies · $187 in 2025
The $187 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $71.58 · 2022: $17.01 · 2023: $99.93 · 2024: $272 · 2025: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $559.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $559.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $106.09 | 2024-2025 | Nexplanon |
| Astellas Pharma US INC | $99.01 | 2021-2025 | Veozah |
| Merck Sharp & Dohme LLC | $82.13 | 2023-2025 | Keytruda, Gardasil 9, Gardasil |
| Evofem Biosciences, INC. | $79.11 | 2021-2025 | Phexxi, Solosec, Phexx |
| Pfizer INC. | $61.46 | 2024 | |
| Sage Therapeutics, LLC | $40.67 | 2024-2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $33.99 | 2023-2024 | Coolseal Generator, Acessa Provu System, Novasure |
| Myriad Women'S Health, INC. | $33.20 | 2023 | Myrisk |
| Exeltis, USA INC. | $27.28 | 2025 | Slynd |
| Sumitomo Pharma America, INC. | $22.23 | 2024 | Myfembree |
| Therapeuticsmd, INC. | $19.36 | 2021 | |
| Abbvie INC. | $17.01 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.20 | 2023 | |
| Aspira Women'S Health INC | $11.05 | 2023 | Ova1 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Dyott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.